GENAPPE PHARMA INVEST

Genappe ·KBO/BCE: BE 0801.925.031

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	20-08-2025	20 d late	2025-00387841
31-12-2023	31-07-2024	21-08-2024	21 d late	2024-00360059

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.22M
Fixed assets	21/28	€1.20M
Financial fixed assets	28	€1.20M
Current assets	29/58	€25k
Cash & bank	54/58	€25k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.22M
Equity	10/15	€53k
Contributions / capital	10/11	€50k
Accumulated profits (losses)	14	€3k
Amounts payable	17/49	€1.17M
Amounts payable after one year	17	€611k
Amounts payable within one year	42/48	€560k
Trade debts payable within one year	44	€8k
Income statement
Gross operating margin	9900	€12k
Operating result	9901	€12k
Financial charges	65	€8k
Result before taxes	9903	€4k
Income taxes	67/77	€759
Net result for the period	9904	€3k
Result to be appropriated	9905	€3k

Legal nameFR	GENAPPE PHARMA INVEST
AbbreviationFR	GPI

Summary